![18F-FDG PET/CT imaging findings in anaplastic large cell lymphoma, a rare subtype of lymphoma | Cancer Imaging | Full Text 18F-FDG PET/CT imaging findings in anaplastic large cell lymphoma, a rare subtype of lymphoma | Cancer Imaging | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40644-019-0278-5/MediaObjects/40644_2019_278_Fig5_HTML.png)
18F-FDG PET/CT imaging findings in anaplastic large cell lymphoma, a rare subtype of lymphoma | Cancer Imaging | Full Text
![Biomedicines | Free Full-Text | Radiotherapy in Follicular Lymphoma Staged by 18F-FDG-PET/CT: A German Monocenter Study Biomedicines | Free Full-Text | Radiotherapy in Follicular Lymphoma Staged by 18F-FDG-PET/CT: A German Monocenter Study](https://www.mdpi.com/biomedicines/biomedicines-09-00561/article_deploy/html/images/biomedicines-09-00561-g001.png)
Biomedicines | Free Full-Text | Radiotherapy in Follicular Lymphoma Staged by 18F-FDG-PET/CT: A German Monocenter Study
![Frontiers | Imaging Lymphoma With F-18 Fluorodeoxyglucose PET-CT: What Should Be Known About Normal Variants, Pitfalls, and Artifacts? Frontiers | Imaging Lymphoma With F-18 Fluorodeoxyglucose PET-CT: What Should Be Known About Normal Variants, Pitfalls, and Artifacts?](https://www.frontiersin.org/files/Articles/826046/fnume-01-826046-HTML/image_m/fnume-01-826046-g001.jpg)
Frontiers | Imaging Lymphoma With F-18 Fluorodeoxyglucose PET-CT: What Should Be Known About Normal Variants, Pitfalls, and Artifacts?
![The role of PET in the first-line treatment of the most common subtypes of non-Hodgkin lymphoma - The Lancet Haematology The role of PET in the first-line treatment of the most common subtypes of non-Hodgkin lymphoma - The Lancet Haematology](https://www.thelancet.com/cms/attachment/fde9dfe2-9e87-40ba-9a1c-03d0ac9138ed/gr1_lrg.jpg)
The role of PET in the first-line treatment of the most common subtypes of non-Hodgkin lymphoma - The Lancet Haematology
![FDG PET/CT in the staging of extent of disease in lymphoma. Coronal... | Download Scientific Diagram FDG PET/CT in the staging of extent of disease in lymphoma. Coronal... | Download Scientific Diagram](https://www.researchgate.net/publication/274145433/figure/fig1/AS:433807590465536@1480439197036/FDG-PET-CT-in-the-staging-of-extent-of-disease-in-lymphoma-Coronal-images-left-to.png)
FDG PET/CT in the staging of extent of disease in lymphoma. Coronal... | Download Scientific Diagram
![FDG‐PET/CT in the management of lymphomas: current status and future directions - El‐Galaly - 2018 - Journal of Internal Medicine - Wiley Online Library FDG‐PET/CT in the management of lymphomas: current status and future directions - El‐Galaly - 2018 - Journal of Internal Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/670ee159-b761-4ad7-8fb9-b336be7e0bf2/joim12813-fig-0001-m.jpg)
FDG‐PET/CT in the management of lymphomas: current status and future directions - El‐Galaly - 2018 - Journal of Internal Medicine - Wiley Online Library
![Diagnostic value of baseline 18FDG PET/CT skeletal textural features in follicular lymphoma | Scientific Reports Diagnostic value of baseline 18FDG PET/CT skeletal textural features in follicular lymphoma | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-03278-9/MediaObjects/41598_2021_3278_Fig1_HTML.jpg)
Diagnostic value of baseline 18FDG PET/CT skeletal textural features in follicular lymphoma | Scientific Reports
![18F-FDG PET/CT for Monitoring the Response of Lymphoma to Radioimmunotherapy | Journal of Nuclear Medicine 18F-FDG PET/CT for Monitoring the Response of Lymphoma to Radioimmunotherapy | Journal of Nuclear Medicine](https://jnm.snmjournals.org/content/jnumed/50/1/8/F2.large.jpg)
18F-FDG PET/CT for Monitoring the Response of Lymphoma to Radioimmunotherapy | Journal of Nuclear Medicine
![Cureus | Diagnostic Yield of FDG-PET/CT, MRI, and CSF Cytology in Non-Biopsiable Neurolymphomatosis as a Heralding Sign of Recurrent Non-Hodgkin's Lymphoma | Article Cureus | Diagnostic Yield of FDG-PET/CT, MRI, and CSF Cytology in Non-Biopsiable Neurolymphomatosis as a Heralding Sign of Recurrent Non-Hodgkin's Lymphoma | Article](https://assets.cureus.com/uploads/figure/file/2479/article_river_24973a10500411e5acddefa0c91d7061-figure_1.png)
Cureus | Diagnostic Yield of FDG-PET/CT, MRI, and CSF Cytology in Non-Biopsiable Neurolymphomatosis as a Heralding Sign of Recurrent Non-Hodgkin's Lymphoma | Article
![Preliminary evidence of imaging of chemokine receptor-4-targeted PET/CT with [68Ga]pentixafor in non-Hodgkin lymphoma: comparison to [18F]FDG | EJNMMI Research | Full Text Preliminary evidence of imaging of chemokine receptor-4-targeted PET/CT with [68Ga]pentixafor in non-Hodgkin lymphoma: comparison to [18F]FDG | EJNMMI Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13550-020-00681-7/MediaObjects/13550_2020_681_Fig1_HTML.png)
Preliminary evidence of imaging of chemokine receptor-4-targeted PET/CT with [68Ga]pentixafor in non-Hodgkin lymphoma: comparison to [18F]FDG | EJNMMI Research | Full Text
![RESISTing the Need to Quantify: Putting Qualitative FDG-PET/CT Tumor Response Assessment Criteria into Daily Practice | American Journal of Neuroradiology RESISTing the Need to Quantify: Putting Qualitative FDG-PET/CT Tumor Response Assessment Criteria into Daily Practice | American Journal of Neuroradiology](https://www.ajnr.org/content/ajnr/40/12/1978/F3.large.jpg)
RESISTing the Need to Quantify: Putting Qualitative FDG-PET/CT Tumor Response Assessment Criteria into Daily Practice | American Journal of Neuroradiology
![FDG‐PET/CT in the management of lymphomas: current status and future directions - El‐Galaly - 2018 - Journal of Internal Medicine - Wiley Online Library FDG‐PET/CT in the management of lymphomas: current status and future directions - El‐Galaly - 2018 - Journal of Internal Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/dc07ffcd-e705-4ac2-894c-903d23bbb772/joim12813-fig-0003-m.jpg)
FDG‐PET/CT in the management of lymphomas: current status and future directions - El‐Galaly - 2018 - Journal of Internal Medicine - Wiley Online Library
![Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin's Lymphoma | Scientific Reports Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin's Lymphoma | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-22032-3/MediaObjects/41598_2022_22032_Fig1_HTML.jpg)